RELX operates legal research databases (LexisNexis), scientific publishing (Elsevier), and risk analytics platforms that serve law firms, academic institutions, and financial services clients through subscription and transactional models. The business benefits from high switching costs, multi-year contracts, and pricing power in mission-critical workflows where customers have limited alternatives. AI-driven document analysis and regulatory compliance tools are driving adoption within its existing customer base, with particular momentum in legal tech and risk management. The forward PE of 15.1 masks a 32% operating margin and 66% gross margin that sit well above software peers, while revenue growth of 2.7% reflects mature markets rather than saturation. At current valuations, the stock prices in minimal margin expansion despite the company's track record of converting incremental revenue into operating profit at rates above 50%.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 18 Oct 2026, 16:04 CEST | Rating | Overvalued | first publication | $39.06 |
| 18 Oct 2026, 01:52 CEST | ACCE price target | $44.00 | $37.00 | $39.06 |
| 28 Sept 2026, 00:00 CEST | Fair value | $33.75 | $34.22 | $25.29 |
| 20 Sept 2026, 00:00 CEST | ACCE price target | $37.00 | first publication | $33.41 |
| 18 Sept 2026, 00:00 CEST | Fair value | $34.22 | $35.51 | $25.47 |
| 16 Sept 2026, 00:00 CEST | Fair value | $35.51 | $34.30 | $26.47 |
| 14 Sept 2026, 00:00 CEST | Fair value | $34.30 | $35.17 | $25.02 |
| 7 Sept 2026, 00:00 CEST | Fair value | $35.17 | $34.02 | $26.25 |
| 4 Sept 2026, 00:00 CEST | Fair value | $34.02 | $35.27 | $26.07 |
| 31 Aug 2026, 00:00 CEST | Fair value | $35.27 | $35.91 | $26.90 |
Answered from RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| RELX RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) | $40.54 | $34 | 21% above | 24.3x | 131.9% | 82 | 65 |
| REL.L RELX | £30.39 | £23 | 34% above | 24.3x | 131.9% | 82 | 65 |
| REN.AS RELX PLC | €36.26 | €27 | 32% above | 25.2x | 131.9% | 82 | 65 |
| CTAS Cintas Corporation Common Stock | $224.10 | $96 | 133% above | 44.2x | 41.4% | 85 | 65 |
| TRI.TO Thomson Reuters Corporation | C$172.41 | C$107 | 60% above | 34.9x | 14.2% | 82 | 69 |
| TRI Thomson Reuters Corporation Common Shares | $123.17 | $75 | 65% above | 32.3x | 14.2% | 82 | 69 |
| CPRT Copart Inc. (DE) Common Stock | $29.00 | $45 | 35% below | 18.8x | 16.2% | 86 | 48 |
Where RELX ranks against its sector peers on each metric.